Ten Tips for Treating Inflammation With Topical Steroids (CME Monograph)

Activity Description

Topical corticosteroids, including dexamethasone, difluprednate, fluorometholone, loteprednol, and prednisolone, are potent anti-inflammatory medications that are prescribed for a wide range of indications in ophthalmology. Their uses include control of inflammation associated with cataract and other ocular surgeries, dry eye disease, eyelid disorders, allergic eye conditions, and anterior uveitis. New topical corticosteroid products have recently been approved, including loteprednol etabonate in a submicron particle formulation. Additionally, some topical corticosteroid products have recently or will soon become available as generic versions. The desired results of this educational activity are for ophthalmologists to help their patients with a variety of inflammatory conditions achieve better outcomes.

Target Audience

This educational activity is intended for ophthalmologists.

Learning Objectives

Upon completion of this activity, participants will be better able to:

    • Discuss the efficacy of newer topical corticosteroids to control ocular inflammation
    • Explain the formulation characteristics and safety of newer topical corticosteroids to control ocular inflammation
    • Identify optimal strategies for control of postoperative inflammation for patients undergoing ophthalmic surgery
    • Identify optimal strategies for control of inflammation for patients with ocular inflammatory disease such as dry eye
    • Use appropriate strategies to discuss the differences between generic and brand name anti-inflammatory agents
    Course summary
    Available credit: 
    • 1.50 AMA PRA Category 1 Credit™
    • 1.50 Participation
    Course opens: 
    10/01/2020
    Course expires: 
    10/31/2021
    Cost:
    $0.00
    Rating: 
    0

    Faculty

    Elizabeth Yeu, MD (Chair)
    Assistant Professor of Ophthalmology
    Eastern Virginia Medical School
    Corneal, Cataract, and Refractive Surgeon
    Partner
    Virginia Eye Consultants
    Norfolk, Virginia

    Eric D. Donnenfeld, MD
    Clinical Professor of Ophthalmology
    New York University Langone Medical Center
    New York, New York
    Founding Partner
    Ophthalmic Consultants of Long Island and Connecticut
    Garden City, New York

    Marguerite B. McDonald, MD, FACS
    Clinical Professor of Ophthalmology
    New York University Langone Medical Center
    New York, New York
    Clinical Professor of Ophthalmology
    Tulane University Health Sciences Center
    New Orleans, Louisiana
    Ophthalmic Consultants of Long Island
    Oceanside, New York

    I. Paul Singh, MD
    President
    Head, Division of Glaucoma
    The Eye Centers of Racine and Kenosha
    Racine, Wisconsin

    Disclosure Policy Statement

    It is the policy of New York Eye and Ear Infirmary of Mount Sinai that the faculty and anyone in a position to control activity content disclose any real or apparent conflicts of interest relating to the topics of the educational activity in which they are participating. They are also required to disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentations. New York Eye and Ear Infirmary of Mount Sinai is committed to providing its learners with quality CME activities and related materials that promote improvements in healthcare and not the proprietary interests of a commercial interest and, thus, has established policies and procedures in place that identify and resolve all conflicts of interest prior to the execution or release of its educational activities. Full disclosure of faculty/planners and their commercial relationships, if any, follows.

    Disclosures

    Eric D. Donnenfeld, MD, had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: Alcon; Allergan; Bausch & Lomb Incorporated; Kala Pharmaceuticals; and Oculis.

    Marguerite B. McDonald, MD, had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: Akorn, Inc; Alcon; Allergan; Bausch & Lomb Incorporated; BlephEx; Dompé US, Inc; GlaxoSmithKline; Johnson & Johnson Vision Care, Inc; OCULUS, Inc; OcuSOFT Inc; Orca Surgical; Quidel Corporation; Strōma Medical Corporation; TearLab Corporation; and Visus Therapeutics.

    I. Paul Singh, MD, had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: Aerie Pharmaceuticals, Inc; Alcon; Allergan; Bausch & Lomb Incorporated; Ellex; Glaukos Corporation; Imprimis Pharmaceuticals, Inc; Ivantis Inc; New World Medical, Inc; Novartis Pharmaceuticals Corporation; Ocular Therapeutix, Inc; Reichert, Inc; Sight Sciences; and Sun Pharmaceutical Industries, Inc.

    Elizabeth Yeu, MD, had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: Alcon; Allergan; Aurea Medical; Avedro, Inc; Avellino Labs; Bausch & Lomb Incorporated; Beaver-Visitec International; Bio-Tissue; BlephEx; Bruder Healthcare; Cassini Technologies; CorneaGen; Dompé US, Inc; EyePoint Pharmaceuticals; Johnson & Johnson Vision Care, Inc; Kala Pharmaceuticals; LENSAR, LLC; Melt Pharmaceuticals; Merck & Co., Inc; Minosys Cellular Devices Inc; Novartis Pharmaceuticals Corporation; Ocular Science; Ocular Therapeutix, Inc; OCuSOFT Inc; Omeros Corporation; Oyster Point Pharma, Inc; ScienceBased Health; Sight Sciences; Sun Pharmaceutical Industries, Inc; Surface Pharmaceuticals Inc; TearLab Corporation; Topcon Medical Systems, Inc; Valeant; and Zeiss; Contracted Research: Alcon; Bio-Tissue; Cassini Technologies; Ocular Science; Topcon; and TearLab Corporation; Ownership Interest (Stock options, or other holdings, excluding diversified mutual funds): Avellino Labs; BlephEx; CorneaGen; Melt Pharmaceuticals; Minosys Cellular Devices Inc; and Oyster Point Pharma, Inc.

    New York Eye and Ear Infirmary of Mount Sinai Peer Review Disclosure

    Priti Batta, MD, has no relevant commercial relationships to disclose.

    Editorial Support Disclosures

    Cheryl Guttman Krader; Melissa Carter, MS; Cynthia Tornallyay, RD, MBA, CHCP; Kimberly Corbin, CHCP; Barbara Aubel; and Michelle Ong have no relevant commercial relationships to disclose.

    Disclosure Attestation

    The contributing physicians listed above have attested to the following:

    1. that the relationships/affiliations noted will not bias or otherwise influence their involvement in this activity;
    2. that practice recommendations given relevant to the companies with whom they have relationships/affiliations will be supported by the best available evidence or, absent evidence, will be consistent with generally accepted medical practice; and
    3. that all reasonable clinical alternatives will be discussed when making practice recommendations.

       

     

    Accreditation Statement

    imageThe New York Eye and Ear Infirmary of Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This educational activity was developed and implemented in collaboration with MedEdicus LLC.

    AMA Credit Designation Statement

    The New York Eye and Ear Infirmary of Mount Sinai designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Grantor Statement

    This continuing medical education activity is supported through an unrestricted educational grant from Bausch & Lomb Incorporated.

    Off-Label Discussion

    This CME activity includes discussion of unlabeled and/or investigative uses of drugs. Please refer to the official prescribing information for each drug discussed in this activity for FDA-approved dosing, indications, and warnings.

    New York Eye and Ear Infirmary of Mount Sinai Privacy & Confidentiality Policies

    https://www.nyee.edu/education/cme

    CME Provider Contact Information

    For questions about this activity, call 917-270-7571.

    Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of New York Eye and Ear Infirmary of Mount Sinai, MedEdicus LLC, Bausch & Lomb Incorporated, or Ophthalmology Times.

    This CME activity is copyrighted to MedEdicus LLC ©2020. All rights reserved. 218

    Available Credit

    • 1.50 AMA PRA Category 1 Credit™
    • 1.50 Participation

    Price

    Cost:
    $0.00
    Please login or register to take this course.

    Clicking Register indicates that you have reviewed the CME information for this activity.

    Learning Method and Medium

    This educational activity consists of a supplement and ten (10) study questions. The participant should, in order, read the learning objectives contained at the beginning of this supplement, read the supplement, answer all questions in the post test, and complete the Activity Evaluation/Credit Request form. To receive credit for this activity, please follow the instructions provided on the post test and Activity Evaluation/Credit Request form. This educational activity should take a maximum of 1.5 hours to complete.